![Thomas Schall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Schall
Vorsitzender bei
IMMUNEERING CORPORATION
Vermögen: 371 905 $ am 30.06.2026
Profil
Thomas J.
Schall was the founder of ChemoCentryx, Inc., founded in 1997, where the titles held included Chairman, President & Chief Executive Officer from 2012 to 2022.
The current job is Chairman at Immuneering Corp., starting in 2025.
Former jobs include Scientist at Genentech, Inc., and Principal at DNAX Research, Inc. from 1993 to 1997.
Education includes a doctorate from Stanford University and an undergraduate degree from Northern Illinois University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.06.2026 | 74’530 ( 0.12% ) | 371 905 $ | 30.06.2026 |
Aktive Positionen von Thomas Schall
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNEERING CORPORATION | Vorsitzender | 16.09.2025 |
Ehemalige bekannte Positionen von Thomas Schall
| Unternehmen | Position | Ende |
|---|---|---|
| CHEMOCENTRYX, INC. | Vorstandsvorsitzender | 20.10.2022 |
DNAX Research, Inc. | Corporate Officer/Principal | 01.01.1997 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Thomas Schall
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
30
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northern Illinois University
 Northern Illinois University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DNAX Research, Inc. | |
Immuneering Corp.
 Immuneering Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, focuses on the oncology and neuroscience product candidates | Health Technology |
Wählen Sie MarketScreener 
